Through a systematic evaluation of the relationship between common driver gene mutations in lung cancer and the expression level of ACACA, we observed frequent upregulation of ACACA expression in patients harboring TP53 mutations or EGFR mutations (Supplementary Figure 3). The gene discussed is EGFR; the disease is lung carcinoma.